Methods for the isolation and identification of MHC-presented peptides from leukaemic cells von Kapoor, K, Barry, D, Mathieu, M, Miles, A.K, Rees, R.C, Dodi, I.A, Creaser, C.S, Bonner, P.L.R

Volltext

Progress made towards the development of a CMV peptide vaccine von Paston, S.J, Dodi, I.A, Madrigal, J.A

Volltext

Artificial Super Para Magnetic Nano APC for Active and Adoptive Immunotherapy von De La Pena, Hugo, Madrigal, J. Alejandro, Bencsik, M., Cave, Gareth W.V., Selman, A., Rees, R.C., Travers, P.J., Dodi, I.A.

Volltext

Hemato Nanotechnology: Artificial APC System for T Cell Adoptive and Active Immunotherapy von De La Pena, H., Madrigal, J.A., Bencsik, M., Cave, G. W.V., Rees, R.C., Travers, P.J., Dodi, I.A.

Volltext

HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy von Chen, F.E., Aubert, G., Travers, P., Dodi, I.A., Madrigal, J.A.

Volltext

CD4+ bias in T cells cloned from a CML patient with active graft versus leukemia effect von Dodi, I.A., Van Rhee, F., Forde, H.C., Roura-Mir, C., Jaraquemada, D., Goldman, J.M., Madrigal, J.A.

Volltext

Graft-versus-leukaemia (GVL) effect post allogeneic BMT is mediated by CML specific T cell clones von Dodi, I.A., van Rhee, F., Forde, H., Perez Cruz, I., Fischer, G., Goldman, J.M., Madrigal, J.A.

Volltext